IL18 and systemic lupus erythematosus: In patients with SLE, free IL-18 is significantly higher than in controls and is correlated with disease activity (7) related to active kidney disease (8); serum IL-18 can be used as a predictive biomarker for the long-term prognosis of renal function in patients with SLE (9).